ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Can Topical Beta-Blockers Reduce the Size of Superficial Infantile Hemangiomas of the Head and Neck?

by Randall A. Bly, MD, Jonathan Perkins, DO, and Sanjay R. Parikh, MD • September 24, 2017

  • Tweet
  • Email
Print-Friendly Version

TRIO Best PracticeTRIO Best Practice articles are brief, structured reviews designed to provide the busy clinician with a handy outline and reference for day-to-day clinical decision making. The ENTtoday summaries below include the Background and Best Practice sections of the original article. To view the complete Laryngoscope articles free of charge, visit Laryngoscope.

You Might Also Like

No related posts.

Explore This Issue
September 2017

Background

The serendipitous discovery of propranolol as a medical therapy for infantile hemangioma in 2008 resulted in a significant change in the treatment paradigm for patients with hemangioma. The use of systemic propranolol is now widely used, either alone or in conjunction with other medications or surgical treatments. Although generally well tolerated, propranolol is typically initiated with observed monitoring of vitals on either an inpatient or outpatient manner due to the risk of adverse events. It is prescribed as a liquid formulation in three doses daily. The most common side effects include hypoglycemia and bradycardia. The use of a topical beta-blocker was initiated soon after systemic treatment was discovered, with the intention of reducing systemic side effects. An ophthalmic formulation of timolol for elevated intraocular pressure was already available. The formulations are timolol maleate 0.1% and timolol 0.5% gel-forming solution. Ocular administration of timolol maleate 0.1% results in high levels of systemic absorption and can cause bradycardia, but this is reduced significantly with use of the 0.5% gel-forming solution. Absorption is likely even less so when applied to the dermis instead of the eye. A formulation of 1% topical propranolol ointment is also available; it is less studied, but reports indicate that it has similar results as topical timolol. The indications for topical therapy are not clearly defined, yet systemic therapy has consensus indications: patients with advanced hemangioma causing functional deficits such as those located adjacent to orbit or in airway, and for those causing significant cosmetic deformity or ulceration. The effectiveness and indications for topical beta-blocker therapy had not been thoroughly studied until recently.

A superficial hemangioma of the nasal columella that was treated with topical beta-blocker and improved significantly. This may be an example of an ideal lesion that is superficial and flat. Laser therapy was not needed after topical beta-blocker therapy. Patient at five months of age (left) and patient at eight months of age (right).

A superficial hemangioma of the nasal columella that was treated with topical beta-blocker and improved significantly. This may be an example of an ideal lesion that is superficial and flat. Laser therapy was not needed after topical beta-blocker therapy. Patient at five months of age (left) and patient at eight months of age (right).
© The American Laryngological, Rhinological and Otological Society, Inc

Best Practice

Topical beta-blocker therapy (timolol 0.5% gel-forming solution is preferred over timolol maleate 0.1% and topical propranolol) is a safe treatment in a select group of patients that meets the following criteria: hemangioma is 1) superficial and 2) nonulcerated. The reported success rate for significant visual reduction of hemangioma size is estimated at 80%. Laser therapy (pulsed dye and Nd:YAG) can be an alternative or adjunctive treatment for lesions that extend into deep subcutaneous tissue if the family prefers to avoid systemic treatment. Limitations in these studies include retrospective cohorts, a lack of control group, possible lesion natural history, and observer bias. For lesions located on mucosal surfaces and in periocular region, systemic treatment with clinical monitoring is favored due to unpredictable systemic absorption with topical therapy. Treatment for advanced hemangiomas that involve the deep soft tissue, mucosal surfaces, or the airway require multimodality treatment, and the adjunctive role for topical beta-blocker therapy is a topic for future study (Laryngoscope. 2017;127:4–5).

Pages: 1 2 | Single Page

Filed Under: Head and Neck, Head and Neck, Practice Focus, TRIO Best Practices Tagged With: clinical treatment, hemangiomas, medical therapy for infantile hemangioma, patient care, topical beta-blockers, treatmentIssue: September 2017

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • Some Studies Predict a Shortage of Otolaryngologists. Do the Numbers Support Them?
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Complications for When Physicians Change a Maiden Name
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Tympanoplasty Tips: Otology Experts Give Advice on the Procedure
    • How Treatment for Obstructive Sleep Apnea (OSA) Is Evolving to Give Patients a Better Night’s Sleep
    • Vestibular Schwannoma Position Relative to Internal Auditory Canal Helps Predict Postoperative Facial Function
    • Vocal Fold Lipoaugmentation Provides Long-Term Voice Improvements for Glottal Insufficiency
    • Upper Lateral Cartilage Mucosal Flap Enables the Successful Closure of Larger Septal Perforations

Polls

Do you think there will be a shortage of otolaryngologists in the next five to 10 years?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2022 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.